Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 289

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

The role of histamine H4receptor in immune and inflammatory disorders

Open access
Zampeli, E, Tiligada, E · 2009 · British Journal of Pharmacology

Abstract

Since its discovery at the beginning of the 20th century, histamine has been established to play a pathophysiological regulatory role in cellular events through binding to four types of G‐protein‐coupled histamine receptors that are differentially expressed in various cell types. The discovery, at the turn of the millennium, that the histamine H 4 receptor is largely expressed in haemopoietic cells as well as its chemotactic properties designate its regulatory role in the immune system. H 4 receptors modulate eosinophil migration and selective recruitment of mast cells leading to amplification of histamine‐mediated immune responses and eventually to chronic inflammation. H 4 receptor involvement in dendritic cell activation and T cell differentiation documents its immunomodulatory function. The characterization of the H 4 as the immune system histamine receptor directed growing attention towards its therapeutic exploitation in inflammatory disorders, such as allergy, asthma, chronic pruritus and autoimmune diseases. The efficacy of a number of H 4 receptor ligands has been evaluated in in vivo and in vitro animal models of disease and in human biological samples. However, before reaching decisive conclusions on H 4 receptor pathophysiological functions and therapeutic exploitation, identification of genetic polymorphisms and interspecies differences in its relative actions and pharmacological profile need to be addressed and taken into consideration. Despite certain variations in the reported findings, the available data strongly point to the H 4 receptor as a novel target for the pharmacological modulation of histamine‐transferred immune signals and offer an optimistic perspective for the therapeutic exploitation of this promising new drug target in inflammatory disorders.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2009.00151.x

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 289

Metadata

Authors
Zampeli, E., & Tiligada, E.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2009-04-08
Volume
157
Issue
1
Pages
24-33
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1751621284
Cited by
289
References
64
FWCI
9.93
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The role of histamine H4receptor in immune and inflammatory disorders. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00151.x
The paper
Zampeli, E., & Tiligada, E. (2009). The role of histamine H4receptor in immune and inflammatory disorders. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00151.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.